Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
Dominik Głodzik(Memorial Sloan Kettering Cancer Center), Johan Staaf(Lund University), Johan Hartman(Karolinska University Hospital), Cecilia Hegardt(Lund University), Lisa Rydén(Lund University), Emma Niméus(Lund University), Lao H. Saal(Domos (Norway)), Hans Ehrencrona(Lund University), Åke Borg(Lund University), Johan Vallon‐Christersson(Lund University), Ana Bosch(Memorial Sloan Kettering Cancer Center), Anna Karlsson(Lund University), Anna Ehinger(Lund University), Jari Häkkinen(Lund University), Anders Kvist(Lund University), Martin Malmberg(Skåne University Hospital), Serena Nik‐Zainal(University of Cambridge), Shamik Mitra(Lund University), Niklas Loman(Lund University), Christer Larsson(Lund University), Christel Reuterswärd(Lund University), Karolina Holm(Lund University), Mattias Aine(Lund University)
Cited by 141
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k